K. Toprak Et Al. , "Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction," Angiology , 2024
Toprak, K. Et Al. 2024. Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction. Angiology .
Toprak, K., KAPLANGÖRAY, M., Inanır, M., Dursun, A., Tascanov, M. B., Altıparmak, I. H., ... Biçer, A.(2024). Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction. Angiology .
Toprak, Kenan Et Al. "Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction," Angiology , 2024
Toprak, Kenan Et Al. "Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction." Angiology , 2024
Toprak, K. Et Al. (2024) . "Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction." Angiology .
@article{article, author={Kenan Toprak Et Al. }, title={Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction}, journal={Angiology}, year=2024}